Pdt Partners, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Pdt Partners, LLC

  • $1.02 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$0.94 - $1.89 $48,174 - $96,860
-51,249 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$1.5 - $9.38 $106,812 - $667,931
-71,208 Reduced 58.15%
51,249 $92,000
Q2 2020

Aug 14, 2020
BUY
$4.79 - $8.39 $586,569 - $1.03 Million
122,457 New
122,457 $1.03 Million

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email